Chondroitin Sulfate Sodium/Sodium Salicylate

硫酸软骨素钠/水杨酸钠

Report date: 2026/03/17 20:00:15
NME

Base Information

Drug NameChondroitin Sulfate Sodium/Sodium Salicylate
Drug Alias NameKashiwadolSALSOROITIN
ClassificationSmall molecules
Mechanisms of ActionLeukocyte elastase inhibitorsCyclooxygenases inhibitors
TargetsLeukocyte elastaseCyclooxygenases
Therapy Area/IndicationsLow Back PainNeuralgia
Global Approved IndicationsLow Back PainNeuralgia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1960/06/01
Country/TerritoryJapan
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesKyowa Criticare Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKyowa Criticare Co Ltd
Inactive CompaniesN/A
Active IndicationsLow Back PainNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A